期刊文献+

子宫内膜间质瘤中雄激素受体(AR)表达的实验研究

Study on Expression of Androgen Receptors in Endometrial Stromal Neoplasms
下载PDF
导出
摘要 目的探讨子宫内膜间质肉瘤中是否表达雄激素受体(AR)。方法研究20例肿瘤标本,其中3例为子宫内膜间质结节(ESN)、14例为低度恶性子宫内膜间质肉瘤(ESS)和3例高度恶性子宫内膜间质肉瘤(UES)、用免疫组化法测定经甲醛溶液固定、石蜡包埋的肿瘤标本。结果雌激素(ER)和孕激素(PR)阳性免疫反应分别有14例(70%)和17例(85%)。此外,9例(45%)为雄激素(AR)免疫反应阳性。在17例ESS和UES中,7例(41%)显示AR阳性。3例子宫内膜间质结节中2例也呈AR阳性。而且,3例高度恶性肉瘤(未分化子宫内膜肉瘤)中有1例ER和PR均为阴性,但AR为阳性免疫反应。结论在子宫内膜间质肉瘤中有AR表达(占45%),必将影响对这类病人的术后处理。 OBJECTIVE investigate whether the presence or obsence of androgen receptor(AR). METHODS 20 tumor spccis were studied,including 3 endometrial stromal nodules, 14 low-grade endometrial sarcomas (ESS), and 3 high-grade endometrial sarcomad (UES). Immunohistochemical analyses for ER, PR, and Ar were performed on formalinfixed, paraffin-embedded archival material. RESULTS Positive immunoreactions for estrogen receptors and progesterone receptors were observed in 14 (70%) and 17 (85 %) cases, respectively, Furthermore, 9 cases (45%) were postive for androgen receptors. Among 17 ESS and UES cases, 7 (41%) revealed postivity for AR. Two of three begin stromal nodules were also positive for AR. Moreover,one of the three high grade sarcomas (undifferentiated endometrial sarcoma) was negative rot both ER and PR,but showed positive reaction for AR (45%). CONCLUSION AR are expressed in endometrial stromal neoplasms(45%). It must have some impact on the postoperative management of the patients.
出处 《海峡药学》 2006年第6期137-139,共3页 Strait Pharmaceutical Journal
关键词 子宫内膜间质内癌 雄激素受体 孕激素受体 雌激素受体 免疫组织化学 Endometrial stromal tumors Androgen receptor Estrogen receptor Progesterone receptor Immunohistochemistry
  • 相关文献

参考文献14

  • 1Aaro LA,Synmonds RE,Dockerty MB Sarcoma of the uterus.A clinical and pathologic study of 177 cases[J].Am J Obstet Gynecol,1996,94:101~109.
  • 2Evans HL Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma[J].Cancer,1982,50:2170~2182.
  • 3Tavassoli FA,Devilece P (2003) World Health Organization classification of tumors;pathology and genetics of tumors of the breast and female genital organs,IARC Press,Lyon.
  • 4Reich O,Regauer S,Urdl W,Laousen M,Winter R Expression of oestrogen and progesterone receptors in lowgrade endometrial stromal sarcomas[J].Br J Cancer,2000,82:1030~1034.
  • 5Gloor E,Schnyder P,Cikes M,Hofstetter J.,Cordey R,Burnier F,Knobel P Endolymphatic stromal myosis.Surgical and hormonal treatment of extensive abdominal recurrence 20 years after hysterectomy[J].Cancer,1982,50:1888~1893.
  • 6Navarro D,Cabrera JJ,Leon L,Chirino R,Fernandez L,Lopez A,Rivero JF,Fernandez P,Falcon O,Jimenez P,et al Endometrial stromal sarcoma expression of estrogen receptors,progesterone receptors and estrogen-induced srp27 (24 K) suggests hormone responsiveness[J].J Steroid Biochem Mol Biol,1992,41:589~596.
  • 7Yeh S,Sampson ER,Lee DK,et al.Functional analysis of androgen receptor N2 terminal and ligand binding domain interacting coregulators in prostate cancer[J].J Formos Med Assoc,2000,99(12):885~894.
  • 8Pickartz H,Beckmann R,Fleige B,Due W,Gerdes J,Stein H Steroid receptors and proliferative activity in nonneoplastic and neoplastic endometria[J].Virchows Arch,1990,417:163~171.
  • 9Bergeron C,Ferenczy A,Shyamala G Distribution of estrogen receptors in various cell types of normal,hyperplastic,and neoplastic human endometrial tissues[J].Lab Invest,1988,58:338~345.
  • 10Brys M,Semczuk A,Baranowski W,Jakowicki J,Krajewska WM Androgen receptor (AR) expression in normal and cancerous human endometrial tissues detected by RT-PCR and immunohistochemistry[J].Anticancer Res,2002,22:1025~1031.

二级参考文献25

  • 1Yeh S,Sampson ER,Lee DK,et al.Functional analysis of androgen receptor N-terminal and ligand binding domain interacting coregulators in prostate cancer[J].J Formos Med Assoc,2000,99(12):885-894.
  • 2Hakimi JM,Schoenberg MP,Rondinelli RH,et al.Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer[J].Clin Cancer Res,1997,3(9):1599-1608.
  • 3Beilin J,Harewood L,Frydenberg M,et al.A case-control study of the androgen receptor gene CAG repeat polymorphism in Australian prostate carcinoma subjects[J].Cancer,2001,92(4):941-949.
  • 4Cude K J,Montgomery JS,Price DK,et al.The role of an androgen receptor polymorphism in the clinical outcome of patients with metastatic prostate cancer[J].Urol Int,2002,68(1):16-23.
  • 5Bratt O,Borg A,Kristoffersson U,et al.CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy,but not to prostate cancer risk[J].Brit J Cancer,1998,81(4):672-676.
  • 6Correa-CerroL,WohrG,Haussler J,et al.(CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population[J].Eur J Hum Genet,1999,7(3):357-362.
  • 7Schoenberg MP,Hakimi JM,Wang SP,et al.Microsatellite mutation (CAG24-18) in the androgen receptor gene in human prostate cancer[J].Biochem Biophys Res Commun,1994,198(1):74-80.
  • 8Maclean HE,Choi WT,Rekaris G,et al.Abnormal androgen receptor binding affinity in subjects with Kennedy′s disease (Spinal and Bulbar Muscular Atrophy)[J] .J Clin Endocrinol Metab,1995,80(2):508.
  • 9Perutz MF,Johnson T,Suzuki M,et al.Glutamine repeats as polar zippers:Their possible role in inherited neurodegenerative diseases [J].Proc Natl Sci USA,1994,91(12):5355-5358.
  • 10Stenoien DL,Cummings CJ,Adamas HP,et al.Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins,proteasome components and SRC-1,and are suppressed by the HJD-2chaperone[J].Hum Mol Genet,1999,8(5):731-741.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部